A PROPENSITY SCORE-MATCHED COMPARISON OF INFLIXIMAB AND ADALIMUMAB IN NAïVE AND NON-NAïVE PATIENTS WITH CROHN'S DISEASE: REAL-LIFE DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD)

Ambrogio Orlando  ¹     Fabio Salvatore Macaluso  ¹     Walter Fries  ²     Antonio Carlo Privitera  ³     Maria Cappello  ⁴     Sebastiano Siringo  ⁵     Gaetano Inserra     Antonio Magnano     Roberto Di Mitri     Filippo Mocciaro     Nunzio Belluardo     Giuseppe Scarpulla     Giovanni Magri     Antonino Trovatello     Antonio Carroccio     Salvatore Genova     Carmelo Bertolami     Robe    
¹ IBD Unit, 'Villa Sofia-Cervello' Hospital,Palermo,Italy
² Inflammatory bowel disease Unit, A.O.U. Policlinico,Messina,Italy
³ IBD Unit, A.O. 'Cannizzaro”, Catania, Italy.,Catania,Italy
⁴ Gastroenterology and Hepatology Unit, A.O.U. Policlinico “G. Giaccone”,Palermo,Italy
⁵ Gastroent

Conference
UEG Week 2018

Citation
United European Gastroenterology Journal 2018; 6 (Supplement 1)